About Mo:re
Mo:re is a company based in Hamburg (Germany) founded in 2023 by David Hackenberger. Mo:re has raised $2.48 million across 1 funding round from investors including Gilson, High-Tech Gründerfonds and IFB Innovationsstarter. Mo:re offers products and services including Mo:re Robot. Mo:re operates in a competitive market with competitors including Pluri, Celloid, AIM Biotech, The Well Bioscience and S-BIO, among others.
- Headquarter Hamburg, Germany
- Founders David Hackenberger
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mo:Re Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.48 M (USD)
in 1 rounds
-
Latest Funding Round
$2.48 M (USD), Seed
Mar 26, 2025
-
Investors
Gilson
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mo:re
Mo:re offers a comprehensive portfolio of products and services, including Mo:re Robot.
Automates 3D cell culture for efficient medical research processes.
Funding Insights of Mo:re
Mo:re has successfully raised a total of $2.48M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.48 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Mo:re
Mo:re has secured backing from 7 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Gilson, High-Tech Gründerfonds and IFB Innovationsstarter.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in high-tech startups by HTGF.
|
Locked | Locked | Locked | |
|
Support is provided for Hamburg's startups through grants and capital.
|
Locked | Locked | Locked | |
|
A venture support network for startups is operated by Nidobirds.
|
Locked | Locked | Locked |
Investor details for Mo:re
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mo:re
Investment portfolio details for Mo:re
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mo:re
Detailed financials for Mo:re
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mo:Re Comparisons
Peer comparison for Mo:re
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mo:re
Mo:re operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pluri, Celloid, AIM Biotech, The Well Bioscience and S-BIO, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Next-generation cell-based products are developed across multiple industries.
|
|
| Locked | Locked | Locked |
3D cell culture solutions for drug development are provided.
|
|
| Locked | Locked | Locked |
Microfluidic 3D cell culture systems are developed and manufactured.
|
|
| Locked | Locked | Locked |
Develops xeno-free hydrogels for 3D cell culture and personalized medicine applications.
|
|
| Locked | Locked | Locked |
Glycan analysis services and kits are offered by S-BIO.
|
Detailed competitors of Mo:re
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mo:Re
Complete news archive for Mo:re
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mo:re
Mo:re was founded in 2023 and raised its 1st funding round 2 years after it was founded.
Mo:re is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.
Lukas Gaats is the current CEO of Mo:re.
Mo:re is a funded company, having raised a total of $2.48M across 1 funding round to date.
Mo:re was founded in 2023 in Hamburg, Germany, within the biotechnology sector. A robotic and software platform is provided for automated, AI-assisted 3D cell cultivation, ensuring cell survival standardization for research publications and regulatory processes. Applications include cell therapy, drug development, screening, and genetic engineering. Operations focus on enhancing reproducibility in medical research workflows.
Mo:re's top competitors include Pluri, Celloid and ExCel Matrix Biological Devices.
Mo:re offers Mo:re Robot.
Mo:re has 7 investors. Key investors include Gilson, High-Tech Gründerfonds, IFB Innovationsstarter, Nidobirds, and NEDGEX.